Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma

Circulating RNAs in serum, plasma or other body liquid have emerged as useful and highly promising biomarkers for noninvasive diagnostic application. Herein, we aimed to establish a serum long non-coding RNAs (lncRNAs) signature for diagnosing nasopharyngeal carcinoma (NPC). In this study, we recruited a cohort of 101 NPC patients, 20 patients with chronic nasopharyngitis (CN), 20 EBV carriers (EC) and 101 healthy controls. qRT-PCR was performed with NPC cells and serum samples to screen a pool of 38 NPC-related lncRNAs obtained from the LncRNADisease database. A profile of three circulating lncRNAs (MALAT1, AFAP1-AS1 and AL359062) was established for NPC diagnosis. By Receiver Operating Characteristic (ROC) curve analysis, this three-lncRNA signature showed high accuracy in discriminating NPC from healthy controls (AUC = 0.918), CN (AUC = 0.893) or EC (AUC = 0.877). Furthermore, high levels of these three lncRNAs were closely related to advanced NPC tumor node metastasis stages and EBV infection. Serum levels of these three lncRNAs declined significantly in patients after therapy. Our present study indicates that circulating MALAT1, AFAP1-AS1 and AL359062 may represent novel serum biomarkers for NPC diagnosis and prognostic prediction after treatment.

[1]  Jingxuan Shi,et al.  miR‐1, regulated by LMP1, suppresses tumour growth and metastasis by targeting K‐ras in nasopharyngeal carcinoma , 2015, International journal of experimental pathology.

[2]  Z. Zeng,et al.  Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1 , 2016, Oncotarget.

[3]  Qiang Wu,et al.  Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma. , 2016, Cancer biomarkers : section A of Disease markers.

[4]  Z. Zeng,et al.  EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC , 2015, Oncotarget.

[5]  Jie Yang,et al.  Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. , 2016, Cancer biomarkers : section A of Disease markers.

[6]  Z. Zeng,et al.  Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma , 2016, Oncotarget.

[7]  Yaoyong Lu,et al.  The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma , 2016, Tumor Biology.

[8]  P. Shueng,et al.  Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma , 2011, Radiation oncology.

[9]  Z. Zeng,et al.  An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma , 2016, Tumor Biology.

[10]  Q. Lu,et al.  The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma , 2016, Tumor Biology.

[11]  Hui-Yun Wang,et al.  RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma , 2016, Cell Death and Disease.

[12]  Akhil Varshney,et al.  Non‐coding RNAs: biological functions and applications , 2015, Cell biochemistry and function.

[13]  H. Yao,et al.  Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value , 2015, BioMed research international.

[14]  Z. Zeng,et al.  Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma , 2015, Oncotarget.

[15]  S. Tsao,et al.  Downregulation of long non‐coding RNA MEG3 in nasopharyngeal carcinoma , 2017, Molecular carcinogenesis.

[16]  Z. Zeng,et al.  Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103 , 2016, Cell Death and Disease.

[17]  Junwei Tang,et al.  HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma , 2015, Cellular Physiology and Biochemistry.

[18]  Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy , 2016, PloS one.

[19]  Hongwei Pan,et al.  Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer , 2016, Oncotarget.

[20]  Qing-quan Wu,et al.  Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma , 2015, Molecular Cancer.

[21]  Z. Zeng,et al.  Epstein–Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma , 2016, Clinical and Translational Oncology.

[22]  Z. Zeng,et al.  AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis , 2015, Tumor Biology.

[23]  Zhifu Sun,et al.  LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer , 2015, Oncotarget.

[24]  Jie Yuan,et al.  Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer , 2016, Oncotarget.

[25]  S. Tsao,et al.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma , 2015, Virologica Sinica.

[26]  Sheida Nabavi,et al.  Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation , 2016, EBioMedicine.

[27]  C. Cavaliere,et al.  Epstein–Barr virus infection and nasopharyngeal carcinoma: the other side of the coin , 2015, Anti-cancer drugs.

[28]  Xiaoguang He,et al.  Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. , 2016, Biochemical and biophysical research communications.

[29]  J. Tang,et al.  Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. , 2013, Current oncology.

[30]  U. Gezer,et al.  Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? , 2016, Tumor Biology.

[31]  C. Gong,et al.  Long non‐coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival , 2013, Cancer science.

[32]  W. Zhang,et al.  LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells , 2016, Oncotarget.

[33]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[34]  A. King,et al.  Early detection of nasopharyngeal carcinoma by plasma Epstein‐Barr virus DNA analysis in a surveillance program , 2013, Cancer.

[35]  Jianchun Yu,et al.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. , 2015, World journal of gastroenterology.

[36]  O. Miura,et al.  Infectious mononucleosis accompanied by clonal proliferation of EBV-infected cells and infection of CD8-positive cells , 2014, International Journal of Hematology.

[37]  S. Zhang,et al.  A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[38]  S. Tsao,et al.  Epstein‐Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization , 2010, International journal of cancer.

[39]  Q. Zheng,et al.  MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A , 2016, Oncotarget.

[40]  Xiao Zhu,et al.  Long noncoding RNA hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways , 2015, Oncotarget.

[41]  Y. Wu,et al.  A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls , 2016, Oncogenesis.

[42]  S. Kannan,et al.  Cell‐free Epstein–Barr virus‐DNA in patients with nasopharyngeal carcinoma: Plasma versus urine , 2016, Head & neck.

[43]  Xiaoqiang Guo,et al.  Long non-coding RNAs: emerging players in gastric cancer , 2014, Tumor Biology.

[44]  Y. Zeng,et al.  Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China , 2014, Cancer.

[45]  W. Jia,et al.  Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China. , 2013, American journal of epidemiology.

[46]  J. Epstein,et al.  Nasopharyngeal carcinoma: current management, future directions and dental implications. , 2008, Oral oncology.

[47]  N. Raab-Traub Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus. , 2015, Current topics in microbiology and immunology.

[48]  Ke Chen,et al.  LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma , 2015, Oncotarget.